Smoking Cessation Adjuncts Are Cost Effective Prior to Elective Revascularization
Smoking cessation adjuncts are cost effective prior to PAD interventions. Varenicline and NRT were the most cost-effective smoking cessation strategies. Our results highlight the value of supplemented coverage for smoking cessation therapies among patients with PAD undergoing revascularization.
Authors
- Mikayla N. Lowenkamp (ORCID: https://orcid.org/0009-0006-9650-516X)
- Natalie Sridharan (ORCID: https://orcid.org/0000-0003-2347-3874)
- Katherine M. Reitz (ORCID: https://orcid.org/0000-0002-9397-321X)
- Kenneth J. Smith (ORCID: https://orcid.org/0000-0001-8088-566X)
- Rabih A. Chaer (ORCID: https://orcid.org/0009-0003-5170-573X)
- Hasan Nassereldine (ORCID: https://orcid.org/0000-0003-2298-3098)
- Michael Madigan
- Edith Tzeng
Institutions
- University of Pittsburgh (US)
- VA Pittsburgh Healthcare System (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Annals of Vascular Surgery
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1016/j.avsg.2025.08.016
- Citations
- 1
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 2.01